Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
BLACKROCK INC BLK |
1,381,983 7.700% |
-366,124 (-20.94%) |
Filing History |
| 2025-02-14 5:18 pm Sale |
2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Armistice Capital, LLC | 1,152,000 6.540% |
-384,000 (-25.00%) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Soleus Capital Master Fund, L.P. | 1,130,679 6.400% |
195,891 (+20.96%) |
Filing History |
| 2025-02-07 1:42 pm Sale |
2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Invesco Ltd. IVZ |
6,449 0.000% |
-1,044,906 (-99.39%) |
Filing History |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
BLACKROCK INC BLK |
1,748,107 9.900% |
1,748,107 (New Position) |
Filing History |
| 2024-11-14 5:18 pm Purchase |
2024-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Armistice Capital, LLC | 1,536,000 8.730% |
1,536,000 (New Position) |
Filing History |
| 2024-11-14 3:33 pm Purchase |
2024-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Soleus Capital Master Fund, L.P. | 934,788 5.300% |
934,788 (New Position) |
Filing History |
| 2024-11-08 09:33 am Purchase |
2024-11-08 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Invesco Ltd. IVZ |
1,051,355 6.000% |
1,051,355 (New Position) |
Filing History |
| 2024-02-14 2:30 pm Purchase |
2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Armistice Capital, LLC | 1,710,000 9.810% |
14,400 (+0.85%) |
Filing History |
| 2024-02-13 5:13 pm Sale |
2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
The Vanguard Group | 895,322 5.130% |
-313,058 (-25.91%) |
Filing History |
| 2024-02-09 12:17 pm Purchase |
2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
MORGAN STANLEY MS |
1,449,060 8.300% |
1,449,060 (New Position) |
Filing History |
| 2024-02-05 5:34 pm Sale |
2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
GOLDMAN SACHS GROUP INC GS |
25,568 0.100% |
-911,439 (-97.27%) |
Filing History |
| 2024-02-02 09:56 am Purchase |
2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Soleus Capital Master Fund, L.P. | 944,258 5.400% |
21,956 (+2.38%) |
Filing History |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
BLACKROCK INC BLK |
1,519,808 8.700% |
51,701 (+3.52%) |
Filing History |
| 2023-06-12 08:21 am Sale |
2023-06-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
FMR CORP | 20,082 0.115% |
-869,119 (-97.74%) |
Filing History |
| 2023-02-22 4:03 pm Purchase |
2023-02-21 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Soleus Capital Master Fund, L.P. | 922,302 5.300% |
922,302 (New Position) |
Filing History |
| 2023-02-14 2:40 pm Purchase |
2022-12-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
GOLDMAN SACHS GROUP INC GS |
937,006 5.400% |
937,006 (New Position) |
Filing History |
| 2023-02-14 1:21 pm Purchase |
2022-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Armistice Capital, LLC | 1,695,600 9.810% |
1,695,600 (New Position) |
Filing History |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
FMR CORP | 889,201 5.144% |
-659,458 (-42.58%) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
The Vanguard Group | 1,208,380 6.990% |
305,568 (+33.85%) |
Filing History |